DHEA: Evidence, Safety, Dosing and Access Questions

DHEA, also called dehydroepiandrosterone or prasterone, is an adrenal precursor hormone involved in androgen and estrogen pathways. Human randomized trials have studied DHEA in aging, menopause-related vaginal symptoms, metabolic markers, physical function, and hormone levels, but evidence quality and relevance vary by use. Chia does not offer DHEA treatment.

What it is

DHEA stands for dehydroepiandrosterone. It is also called prasterone in some clinical and research settings, especially when vaginal or intravaginal forms are being studied for menopause-related symptoms 1.

Names: DHEA, dehydroepiandrosterone, and prasterone

DHEA, dehydroepiandrosterone, and prasterone refer to the same core hormone compound in the supplied human literature. Trials have studied vaginal dehydroepiandrosterone for genitourinary symptoms of menopause, including vulvovaginal atrophy and dyspareunia, and have also studied oral DHEA in aging humans 1 3.

How DHEA differs from DHEA-S

DHEA-S means dehydroepiandrosterone sulfate. It is related to DHEA, but it is not the same lab value or same molecule. The supplied trials focus on DHEA or prasterone interventions, not on using DHEA-S alone to predict who will benefit 3 8.

A key practical point: a blood level may be one part of the picture, but it does not automatically prove that a person needs treatment or will feel better. The human trials studied defined groups, routes, and outcomes; they do not show that a single DHEA-S value predicts benefit for every patient 3 8.

Mechanism of action

DHEA is studied as an adrenal precursor steroid that can influence androgen and estrogen pathways. In human endocrine research, adding DHEA to combined oral contraceptives was studied for maintaining physiological testosterone levels, which supports its role in sex-hormone pathways 4.

DHEA as an adrenal precursor steroid

A precursor is a building block the body can use to make other hormones. For DHEA, the clinically relevant pathways involve androgens, such as testosterone, and estrogens; however, the effect depends on tissue, route, age, sex, baseline hormone status, and the study population 4 6.

Relationship to testosterone, estrogens, and local tissue conversion

The word “local” matters. Vaginal DHEA has been studied for local and systemic effects, while oral DHEA has been studied in aging and postmenopause-related research; those routes should not be treated as interchangeable 2 6.

Why blood levels do not automatically predict benefit

Human trials can show whether a studied intervention changed a measured endpoint in a defined group. They do not prove that every person with a “low” DHEA or DHEA-S lab result should use DHEA, or that a higher number will translate into better symptoms, strength, metabolism, or longevity 3 8.

Evidence

DHEA has evidence grade A for quantity and study design because multiple human randomised controlled trials are indexed. That grade does not mean DHEA is proven for every claimed benefit, and it does not mean it is safe for every person 3 5 8.

Menopause and genitourinary symptoms

Vaginal dehydroepiandrosterone and intravaginal prasterone have been studied for genitourinary symptoms of menopause, including vulvovaginal atrophy and dyspareunia. One publication directly asks whether the evidence is sufficient, so the careful reading is that this is an active evidence area, not a blanket answer for every menopause symptom 1.

Another randomized trial studied systemic and local effects of vaginal DHEA, which is important because local vaginal use can still raise questions about body-wide hormone effects. Twice-weekly intravaginal dehydroepiandrosterone has also been studied for vulvovaginal atrophy, showing that frequency and route are part of the evidence question 2 9.

Aging, strength, physical function, and metabolic markers

DHEA replacement has been studied in aging humans, but aging research should not be translated into broad anti-aging or lifespan claims. The supplied trial record supports discussion of studied endpoints, not claims that DHEA slows aging or extends life 3.

In frail older women, DHEA combined with exercise was studied for muscle strength and physical function. That finding belongs in a specific frailty-and-exercise context; it should not be used as a general performance claim for younger or healthy adults 5.

DHEA replacement has also been studied in aging humans for insulin resistance and inflammatory cytokines. Biomarker findings are not the same as proven prevention of diabetes, heart disease, or age-related disease, and individual results vary 8.

Hormone levels and contraceptive-related testosterone changes

Adding DHEA to combined oral contraceptives has been studied for endocrine effects and maintaining physiological testosterone levels. This is a hormone-level research context, not a general recommendation to combine DHEA with contraceptives without clinician oversight 4.

Fertility and ovarian-reserve research contexts

DHEA-related hormone pathways also appear in fertility-adjacent research. For example, a randomized trial in cancer patients undergoing oocyte cryopreservation studied how letrozole affected follicular fluid steroid concentrations; this supports careful discussion of steroid-hormone context, not a simple fertility claim for DHEA 7.

Evidence limits: quantity of trials is not the same as proven benefit

The honest summary is mixed: DHEA has many human studies, but the route, population, and endpoint matter. Menopause-related vaginal symptoms, frailty with exercise, aging biomarkers, contraceptive-related hormone levels, and postmenopause endocrine responses are different questions and should not be merged into one “DHEA benefits” claim 1 5 6 8.

What studies exist

This table is retrieved from PubMed and ClinicalTrials.gov rather than assembled by hand, so it shows what is indexed — including the absences. Last retrieved 2026-09-09.

Reported dosing ranges

DHEA dosing should not be copied from an article or online calculator. The table below reports only what the supplied study records identify by route, frequency, or study context; it is not dosing advice.

Why studied doses are not dosing advice

A research dose is chosen for a trial protocol. It does not account for your symptoms, hormone labs, cancer history, fertility plans, medications, or side-effect risk, so it should not be used as a personal plan 2 4.

Why dose, route, sex, age, and baseline hormone levels matter

Oral DHEA, vaginal DHEA, and DHEA added to a contraceptive are different exposures. A dose studied in one setting cannot be assumed to have the same risks or effects in another, especially when sex-hormone pathways are involved 2 4 6.

Legal status

Our regulatory log holds no confirmed federal action for DHEA. That means we have not found one with a primary source — not that none exists.

This section is generated from a dated log of federal actions rather than written by hand, and it is re-checked daily against the Federal Register and FDA sources. Last checked 2026-09-09. See the full legal-status tracker for every compound we follow.

Safety

DHEA safety depends on route, dose, hormone status, and the person’s medical context. The supplied trials include endocrine, local, and systemic-effect research, but they should not be read as a full safety guarantee for unsupervised use 2 4.

Hormone-related effects to discuss with a clinician

Because DHEA is tied to androgen and estrogen pathways, hormone-related effects are the main safety topic to raise with a clinician. Trials have studied testosterone-related endocrine effects and systemic effects after vaginal DHEA, which is why medical history and monitoring may matter 2 4.

Populations that need extra caution

People in fertility care, menopause care, oncology care, or contraceptive-related hormone care need extra caution because the supplied evidence includes those kinds of hormone-sensitive settings. A cancer-patient oocyte cryopreservation study and vaginal DHEA systemic-effect study show why context matters 2 7.

Why monitoring may matter when hormones are involved

Monitoring may include symptoms, medication review, and labs when a clinician thinks they are appropriate. The reason is not that a lab number alone decides treatment; it is that DHEA can affect hormone pathways that differ by route and person 4 8.

Risks of unregulated supply

A product sold for “research use only” is not the same as a medication prepared for a patient after clinical review. With unregulated supply, the core risks are identity, strength, impurity, and whether the product was made for human use; the supplied clinical studies do not validate products from research-chemical vendors 1 2.

Interactions

DHEA interaction research in the supplied records is limited. The records support concern about hormone-pathway overlap, especially with contraceptive, menopause, fertility, and oncology contexts, but they do not provide a complete interaction map 4 7.

Hormone therapies and androgen- or estrogen-sensitive conditions

DHEA has been studied in settings that involve testosterone, estrogens, and local or systemic hormone effects. That makes it important to review hormone therapy, hormone-sensitive conditions, and symptom goals before considering use 2 4.

Fertility, contraceptive, oncology, and menopause-care contexts

DHEA-related decisions can overlap with fertility treatment, combined oral contraceptives, oncology-related fertility preservation, and menopause care. The supplied studies include those contexts, but they do not prove that combining DHEA with these care plans is safe or useful for every person 4 7 1.

Why a full medication and supplement list matters

A full medication and supplement list helps a clinician spot overlapping hormone effects and avoid guessing. Where interaction studies are not available in the supplied record set, that absence should be treated as uncertainty, not reassurance 2 4.

How to obtain it legally

DHEA is not offered by Chia. We also do not offer dehydroepiandrosterone, prasterone, or 7-keto DHEA treatment.

Start with symptoms, goals, medical history, and labs when appropriate

For hormone-related questions, the safer process starts with your symptoms, goals, medical history, medication list, and labs when appropriate. If the issue is menopause, sexual health, fatigue, strength, or metabolic health, the right next step is a clinical evaluation rather than choosing a hormone based on a single search result.

Use clinician evaluation rather than research-chemical vendors

A clinician evaluation looks at whether a treatment fits the person, not just whether a product can be purchased. A licensed pharmacy is part of medical care; a “research use only” vendor is not a substitute for diagnosis, prescription review, identity testing, sterility standards, or follow-up.

Where Chia fits: hormone and longevity care, but not DHEA

At Chia, our providers evaluate patients online for treatments we actually offer, including estradiol, progesterone, and the HRT for Women protocol where clinically appropriate. A prescription requires a medical evaluation and is not guaranteed; Chia medications are compounded in the US by state-licensed 503A pharmacies and shipped to the patient’s door, and compounded drugs are not FDA-approved.

If you are comparing hormone options, our educational guides on bioidentical hormone replacement therapy, progesterone, testosterone boosters, and healthy aging can help you prepare better questions for a licensed clinician.

Keep reading

Hormone Health

Testosterone: Evidence, Safety, Dosing, and Access

Hormones

Testosterone Boosters: What Works, What Doesn’t, and When to See a Doctor

Hormones

How to Naturally Increase Testosterone: An Evidence-Based Guide